Searched for
BIOGEN FDA APPROVAL
Pill for postpartum depression can help new mothers boost their mental well-beingThe US Food and Drug Administration has approved the first pill to treat postpartum depression. The medication is fast-acting, with clinica...05 Aug, 2023, 06.12 PM IST- FDA approves breakthrough pill for severe postpartum depression in new mothersZurzuvae provides hope for mothers struggling with life-threatening postnatal depression.05 Aug, 2023, 08.15 AM IST
- FDA approves first postpartum depression pillThe FDA has approved a pill, Zurzuvae, to treat severe depression after childbirth, a condition that affects thousands of new mothers in th...05 Aug, 2023, 08.01 AM IST
- New cancer-like rating system introduced for Alzheimer's diagnosisExperts have developed a new seven-point rating scale for diagnosing Alzheimer's disease based on cognitive and biological changes in patie...17 Jul, 2023, 08.26 AM IST
- S&P 500 and Nasdaq close at highest since April 2022The S&P 500 and Nasdaq closed at their highest levels since April 2022, bolstered by gains in market heavyweights Amazon, Apple, and Tesla....13 Jun, 2023, 07.42 AM IST
- Wall St climbs with focus on inflation data, Fed decisionWall Street indexes extended their recent rally as investors awaited inflation data and the Federal Reserve's interest rate decision. The L...12 Jun, 2023, 11.51 PM IST
- Pharma CMOs may feel heat as USFDA approves fewer new drugs, GlobalData report saysInflation and declining FDA drug approvals will pose challenges for pharma contract manufacturers in 2023, stated GlobalData in its latest ...06 Apr, 2023, 05.31 PM IST
- New Alzheimer drug 'lecanemab' by Eisai Co and Biogen shows positive results but......, read what study saysThe ‘Eisai’ and ‘Biogen’ drug slowed cognitive decline in study participants, but many experienced brain bleeds, swelling, or other side ef...30 Nov, 2022, 07.12 PM IST
- Roche's Alzheimer's drug fails to meet goal in long awaited trialRoche's Alzheimer's drug candidate could not be shown to markedly slow dementia progression in two drug trials, leaving rivals Biogen and E...14 Nov, 2022, 02.50 PM IST
- Lecanemab: All about the Alzheimer's drug that shows promiseClinical trials on 1800 patients with early-stage Alzheimer's has showed that Lecanemab slows the advance of the disease.30 Sep, 2022, 05.17 PM IST
- Biogen halves price of Alzheimer's drug to $28,200Biogen's $56,000 per year treatment price for an average weight person was seen as a significant cost burden on Medicare, which covers more...20 Dec, 2021, 08.50 PM IST
- FDA approves much-debated Alzheimer's drug panned by expertsThe new drug, which Biogen developed with Japan's Eisai Co., did not reverse mental decline, only slowing it in one study. The drug is give...08 Jun, 2021, 11.38 AM IST
- US stocks claw back much of an early loss and finish mixedOn Thursday investors will get more information on how much consumer prices rose last month. Technology stocks, banks and industrial compan...08 Jun, 2021, 07.33 AM IST
- Dow Jones flat as investors await US inflation dataInvestors remained on the fence ahead of key inflation data later this week.07 Jun, 2021, 09.33 PM IST
- FDA panel reviews first new Alzheimer's drug in 2 decadesA panel of outside experts meets Friday to advise the Food and Drug Administration on aducanumab, a drug from Cambridge, Massachusetts-base...06 Nov, 2020, 12.10 PM IST
- US needs Indian generic products and India needs US: Kewal Handa, former MD at Pfizer LimitedAlmost one-third of Hillary’s expenses for elections are funded by the pharmaceutical companies with the hope that they can swing to our si...08 Nov, 2016, 11.36 AM IST
Load More
